When.com Web Search

  1. Ads

    related to: drugs that cause macular damage treatment options for seniors list

Search results

  1. Results From The WOW.Com Content Network
  2. Drug abuse retinopathy - Wikipedia

    en.wikipedia.org/wiki/Drug_abuse_retinopathy

    Drug abuse retinopathy is damage to the retina of the eyes caused by chronic drug abuse. Types of retinopathy caused by drug abuse include maculopathy, Saturday night retinopathy, and talc retinopathy. Common symptoms include temporary and permanent vision loss, blurred vision, and night blindness.

  3. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    These drugs are approved to treat neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy. View the ...

  4. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. [1]

  5. Retinopathy - Wikipedia

    en.wikipedia.org/wiki/Retinopathy

    The first mechanism is indirect damage by altering the blood vessels that supply the retina. In the case of hypertension, high pressures in the system cause the walls of the artery to thicken, which effectively reduces the amount of blood flow to the retina. [8] This reduction in flow causes tissue ischemia leading to damage.

  6. Anti-VEGF - Wikipedia

    en.wikipedia.org/wiki/Anti-VEGF

    Anti–vascular endothelial growth factor therapy, also known as anti-VEGF (/ v ɛ dʒ ˈ ɛ f /) therapy or medication, is the use of medications that block vascular endothelial growth factor. This is done in the treatment of certain cancers and in age-related macular degeneration.

  7. Ranibizumab - Wikipedia

    en.wikipedia.org/wiki/Ranibizumab

    Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab.It is an anti-angiogenic [16] that is approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion.